热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PerCP anti-mouse CD8a Antibody
产品名称：
PerCP anti-mouse CD8a Antibody
产品类别：
抗体
产品编号：
100731
产品应用：
100731
[价格]
规格 价格 库存
25µg ￥ 1188 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP has a maximum absorption of 482 nm and a maximum emission of 675 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  30. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Sandu I, et al. 2020. Nat Commun. 11:4454. PubMed
  2. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  3. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  4. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  5. Feola S, et al. 2022. Front Immunol. 13:826164. PubMed
  6. Fisher E, et al. 2021. Front Immunol. 11:602254. PubMed
  7. Singer M et al. 2016. Cell. 166(6):1500-1511 . PubMed
  8. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  9. Khalsa JK, et al. 2020. Nat Commun. 3.175. PubMed
  10. Zhang L, et al. 2020. Front Oncol. 1.243055556. PubMed
  11. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  12. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  13. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  14. Mier-Aguilar C, et al. 2016. PLoS One. 11:e0168155. PubMed
  15. Choudhari R, et al. 2016. Blood. 127: 1297 - 1306. PubMed
  16. Peng X, et al. 2014. J Immunol. 193:1268. PubMed
  17. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  18. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  19. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  20. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  21. Thomas S, et al. 2019. J Immunother Cancer. 7:214. PubMed
  22. Yang X, et al. 2019. Oncotarget. 10:4180. PubMed
  23. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  24. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  25. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  26. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  27. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  28. Wagle MV, et al. 2021. Nat Commun. 12:2782. PubMed
  29. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  30. Levi J, et al. 2020. J Nucl Med. . PubMed
  31. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  32. Leisegang M, et al. 2016. Clin Cancer Res. 22: 2734 - 2743. PubMed
  33. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  34. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  35. Menotti M, et al. 2019. Nat Med. 25:130. PubMed
  36. Sood S, et al. 2016. J Immunol. 197: 429 - 440. PubMed
  37. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  38. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  39. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  40. Sun Z, Xiao Z 2013. Biochem Biophys Res Commun. 435:472. PubMed
  41. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  42. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  43. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  44. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  45. Zhang X, et al. 2019. Nat Commun. 10:4158. PubMed
  46. Sandu I, et al. 2020. Cell Reports. 32(8):108078. PubMed
  47. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  48. Miyauchi E, et al. 2020. Nature. 585:102. PubMed
  49. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  50. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  51. Castiglioni P, et al. 2017. PLoS Negl Trop Dis. 10.1371/journal.pntd.0005240. PubMed
  52. Roy S, et al. 2021. Nat Commun. 12:3182. PubMed
  53. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  54. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  55. Brennd?rfer E, et al. 2014. J Immunol. 192:1671. PubMed
  56. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  57. Li X, et al. 2016. MBio. 7: 02232-15. PubMed
  58. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  59. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  60. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  61. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  62. Rinaldi S, et al. 2021. PLoS Pathog. 17:e1009533. PubMed
  63. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  64. Hickey JW, et al. 2018. Biomaterials. 187:105. PubMed
  65. Hosaka K, et al. 2020. Nat Commun. 3.030555556. PubMed
  66. Li X, et al. 2022. Cell Death Differ. . PubMed
  67. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  68. Jacque E, et al. 2014. J Exp Med. 211:2085. PubMed
  69. Sch?fer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  70. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  71. Bessell CA, et al. 2020. JCI Insight. 5:. PubMed
  72. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  73. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  74. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  75. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
RRID
AB_893427 (BioLegend Cat. No. 100731) AB_893423 (BioLegend Cat. No. 100732)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8a on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线